STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Vitrolife (STO:VITR): * Sales increased by 28 percent during the third quarter and amounted to SEK 65.2 (50.9) million. Sales during the first nine months amounted to SEK 207.3 (166.1) million, an increase of 25 percent.
